CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...